drugset
drugset / Trial / NCT00378404

Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC

NCT00378404 ↗

Phase 1 Terminated 10 enrolled Susanne Arnold Kentucky Lung Cancer Research Program · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the maximum tolerated dose of low-dose radiation in combination with Docetaxel in recurrent or metastatic non-small cell lung cancer for second-line therapy.

Timeline

Start
2004-11
Primary completion
2009-06
Completion
2010-01

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual”

Drugs

EvaluationDrugModalityDoseRoute
Background Docetaxel Small molecule 30 mg/m2 Intravenous

Indications

non-small cell lung carcinoma